EU MDR Clinical Documentation Kit
€399.00
ISO 13485 & MDSAP Ready
Editable Word & Excel
ISO 13485 / MDSAP / FDA QMSR
Used by 100+ quality teams
EU MDR Clinical Documentation Kit — Complete Bundle
Audit-ready clinical and post-market documentation for Regulation (EU) 2017/745. 8 professionally drafted Word templates covering the full clinical lifecycle: from Clinical Evaluation Plan to PSUR.
Whats included
- Clinical Evaluation Plan (CEP) — Article 61 + Annex XIV-A. PICO framework, equivalence criteria, state-of-the-art search protocol, GSPR mapping.
- Clinical Evaluation Report (CER) — Article 61 + Annex XIV-A. Executive summary, preclinical evidence, GSPR conformity, benefit-risk analysis.
- Clinical Development Plan (CDP) — Annex XIV-A. Residual uncertainties, GSPR cluster status, planned investigations, registry/RWD strategy.
- Post-Market Surveillance Plan — Article 83-84 + Annex III §1.1. Proactive/reactive inputs, indicators, vigilance, FSCA, trend reporting.
- Periodic Safety Update Report (PSUR) — Article 86. Production volume, status of previous PSUR actions, risk-benefit analysis.
- PMCF Plan — Article 61(11) + Annex XIV-B. Activity programme, method justification, acceptance criteria, threshold triggers.
- PMCF Evaluation Report — Annex XIV-B. Activities executed vs planned, integrated analysis, impact on benefit-risk.
- SSCP — Article 32. Professional and lay sections for Class III and implantable devices, ready for Eudamed publication.
Aligned with
EU MDR (Regulation 2017/745) Articles 32, 61, 83-86 and Annexes III, XIV-A, XIV-B. References to MDCG 2019-9, 2020-1, 2020-5, 2020-6, 2020-7, 2020-8, 2020-13, 2022-21, 2024-10.
Format and delivery
8 Word .docx templates + 1 Excel Master Index + README. Delivered as a single ZIP with organised folder structure (224 KB). Instant download after purchase. Lifetime access to updates.
License
Single-organisation license. Internal use across multiple device families and projects. Redistribution outside the organisation is not permitted.
€399.00




